Structures by: Pfaffenrot E.
Total: 4
1-[(3<i>RS</i>,4<i>RS</i>)-1-Benzyl-4-methylpiperidin-3-yl]- 1,6-dihydroimidazo[4,5-<i>d</i>]pyrrolo[2,3-<i>b</i>]pyridine hemihydrate
C21H23N5,0.5(H2O)
Acta Crystallographica Section E (2012) 68, 10 o3052
a=17.3606(19)Å b=10.0422(10)Å c=22.995(2)Å
α=90.00° β=100.965(3)° γ=90.00°
<i>N</i>-[(3<i>RS</i>,4<i>SR</i>)-1-Benzyl-4-methylpiperidin-3-yl]-1-(4- methylphenylsulfonyl)-5-nitro-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-4-amine
C27H29N5O4S
Acta Crystallographica Section E (2012) 68, 10 o3000
a=29.5164(12)Å b=9.1388(2)Å c=23.3008(9)Å
α=90.00° β=124.803(3)° γ=90.00°
<i>N</i>-[(3<i>RS</i>,4<i>RS</i>)-1-Benzyl-4-methylpiperidin-3-yl]- 5-nitro-1-phenylsulfonyl-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine-4-amine
C27H29N5O4S
Acta Crystallographica Section E (2012) 68, 10 o3051
a=17.2626(10)Å b=11.5411(8)Å c=13.1313(9)Å
α=90.00° β=98.443(3)° γ=90.00°
2-(3-{(3<i>R</i>,4<i>R</i>)-4-Methyl-3-[methyl(7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-4-yl)amino]piperidin-1-yl}oxetan-3-yl)acetonitrile monohydrate
C18H24N6O,H2O
Acta Crystallographica Section E (2014) 70, 4 o382-o383
a=6.6088(6)Å b=10.1483(8)Å c=26.813(2)Å
α=90.00° β=90.00° γ=90.00°